Wernicke-Korsakoff Syndrome

1. Clinical Overview

Summary

Wernicke-Korsakoff Syndrome (WKS) represents a spectrum of neuropsychiatric manifestations resulting from severe thiamine (Vitamin B1) deficiency. It encompasses two distinct but related clinical entities that form a continuum of the same pathological process:

1. Wernicke's Encephalopathy (WE): An acute, potentially reversible neurological emergency characterized by the classical triad of confusion, ataxia, and ophthalmoplegia. Without immediate treatment, mortality approaches 17-20%. [1,2]

2. Korsakoff's Syndrome (KS): The chronic, largely irreversible neuropsychiatric sequela characterized by profound anterograde amnesia (inability to form new memories), retrograde amnesia, and confabulation. This develops in approximately 80% of untreated or inadequately treated WE survivors. [3,4]

While historically associated with chronic alcohol use disorder, WKS can occur in any state of severe malnutrition or malabsorption. Non-alcoholic causes include hyperemesis gravidarum, anorexia nervosa, post-bariatric surgery states, chronic vomiting from any cause, malignancy, and prolonged parenteral nutrition without adequate thiamine supplementation. [5,6]

The cornerstone of management is immediate, high-dose intravenous thiamine (typically Pabrinex in the UK), administered before any glucose-containing solutions. This critical sequence prevents the catastrophic depletion of remaining thiamine stores that can precipitate acute WE in already-deficient patients. [7,8]

Epidemiological Significance

The true prevalence of WKS is significantly underestimated. Autopsy studies consistently demonstrate that WE is diagnosed clinically in only 20% of cases subsequently confirmed at post-mortem examination. Among chronic alcoholics undergoing autopsy, the prevalence ranges from 12.5% to 14%, suggesting massive under-recognition in clinical practice. [9,10] This diagnostic failure represents a critical gap in emergency and hospital medicine, as early treatment can prevent irreversible neurological damage.

In the general hospital population, risk groups extend beyond alcoholism. Oncology patients receiving chemotherapy, pregnant women with severe hyperemesis, post-operative bariatric surgery patients, and individuals with malabsorptive gastrointestinal disorders all face elevated risk. The emerging recognition of WKS in these populations has significant medicolegal implications, particularly in obstetrics where missed WE in hyperemesis gravidarum has led to litigation. [11,12]

Key Clinical Messages

The Classic Triad is the Exception: The historical triad of confusion, ataxia, and ophthalmoplegia is present in only 10-16% of patients at initial presentation. Relying on this triad will result in missing the majority of cases. The Caine criteria (requiring only 2 of 4 features: dietary deficiency, eye signs, cerebellar dysfunction, or altered mental state) demonstrate superior sensitivity and should guide clinical suspicion. [13,14]

The "Sugary Death" Phenomenon: Thiamine pyrophosphate functions as an essential cofactor in glucose metabolism, particularly for the enzyme pyruvate dehydrogenase in the Krebs cycle. Administering a glucose load to a thiamine-deficient patient consumes their remaining thiamine stores, precipitating or worsening WE. The mnemonic "Thiamine Before Dextrose" is a critical emergency medicine principle. This applies to both intravenous dextrose and oral glucose in hypoglycaemic alcoholic patients. [15,16]

Magnesium Dependency: Thiamine requires magnesium as a cofactor for conversion to its active form, thiamine pyrophosphate. Chronic alcoholics commonly have concomitant hypomagnesaemia due to poor intake and renal losses. Without magnesium repletion, thiamine supplementation may be ineffective. Aggressive magnesium replacement should accompany thiamine therapy. [17]

Non-Alcoholic WKS: Clinicians must maintain high suspicion in non-drinking populations. Pregnant women with prolonged vomiting, patients post-gastric bypass surgery, individuals with cancer receiving chemotherapy, and those with restrictive eating disorders are all at risk. Failure to recognize WKS in these groups often results in preventable permanent disability. [18]

Clinical Pearls

Eye Examination is Critical: The earliest and most sensitive sign of WE is often horizontal nystagmus or lateral rectus (CN VI) palsy. These ocular signs may precede confusion by hours to days. Importantly, eye signs often respond dramatically to IV thiamine within hours, sometimes before other neurological features improve. Complete ophthalmoplegia indicates advanced disease. [2,14]

The Magnesium Mandate: Thiamine therapy fails without adequate magnesium. Standard practice should include checking and aggressively replacing magnesium (target > 0.85 mmol/L) in all patients receiving thiamine. In alcoholics, assume hypomagnesaemia and supplement empirically. [17]

Hyperemesis Gravidarum - High-Stakes Diagnosis: WE in pregnancy is a medical emergency with significant litigation risk. Any pregnant woman with prolonged vomiting (typically > 3 weeks) who develops confusion, ataxia, or visual disturbance should be assumed to have WE and treated immediately. Do not wait for investigations. [11,12]

Refeeding Syndrome Overlap: Patients at risk for WKS (malnourished, alcoholic) are also at risk for refeeding syndrome. When initiating nutritional support, monitor and replace phosphate, potassium, and magnesium aggressively while ensuring adequate thiamine. [19]

Institutionalization Reality: Patients who progress to Korsakoff's syndrome typically require long-term institutional care. They lack insight into their memory deficits (anosognosia), cannot form new memories, and pose safety risks if left unsupervised. Only 20% show significant recovery. Families need early, realistic counseling about prognosis. [3,4]

---

2. Epidemiology and Risk Factors

Incidence and Prevalence

General Population:

• Autopsy prevalence in Western populations: 0.4-2.8% [9,10]
• Clinical diagnosis rate: Only 20% of autopsy-confirmed cases [9]
• This represents a 5-fold under-diagnosis in clinical practice

Alcohol Use Disorder Population:

• Autopsy prevalence among chronic alcoholics: 12.5-14% [9,10]
• Clinical WE diagnosis in hospitalized alcoholics: 1-3% [13]
• Progression to Korsakoff's syndrome after untreated WE: 80% [3]
• Mortality from acute untreated WE: 17-20% [1,2]

Non-Alcoholic Populations:

• Hyperemesis gravidarum: WE incidence estimated at 0.04-0.13% of severe cases [11]
• Post-bariatric surgery: Estimated 1-5% within first year [20]
• Oncology patients on chemotherapy: Incidence poorly characterized but increasingly recognized
• Prolonged parenteral nutrition without supplementation: High risk, incidence varies by protocol

Demographics

Age: WKS can occur at any age but peaks in the 40-60 year age group, correlating with peak prevalence of chronic alcoholism. Non-alcoholic cases in younger women (hyperemesis, eating disorders) and older adults (malabsorption, malignancy) are increasingly recognized. [5,6]

Sex: Historically more common in males (reflecting higher rates of alcohol use disorder), but the sex ratio is equalizing as non-alcoholic causes are better recognized. Pregnancy-related WE affects only females, while eating disorder-related WE has female predominance. [11,12]

Ethnicity: No intrinsic ethnic predisposition exists, but populations with higher rates of alcohol use disorder or dietary thiamine deficiency (polished rice as staple without fortification) show higher prevalence. Southeast Asian populations historically showed higher beriberi rates before food fortification programs. [21]

Risk Factors

High-Risk Groups (Require High Index of Suspicion)

1. Chronic Alcohol Use Disorder

• Mechanisms: Poor dietary intake, impaired intestinal absorption, reduced hepatic storage, increased thiamine requirements
• Alcohol directly inhibits active thiamine transport in the intestinal epithelium
• Concurrent liver disease reduces thiamine storage capacity
• Risk proportional to duration and quantity of alcohol consumption [13,14]

2. Gastrointestinal Malabsorption

• Post-bariatric surgery (especially Roux-en-Y gastric bypass): Bypasses duodenum where thiamine absorption occurs [20]
• Coeliac disease: Villous atrophy impairs absorption
• Crohn's disease: Particularly with extensive small bowel involvement
• Chronic pancreatitis: Impaired digestion and absorption
• Short bowel syndrome: Reduced absorptive surface area

3. Prolonged Vomiting States

• Hyperemesis gravidarum: Typically requires > 3 weeks of severe vomiting [11,12]
• Chemotherapy-induced nausea: Particularly platinum-based regimens
• Gastroparesis: Diabetes-related or idiopathic
• Pyloric stenosis: In adults (rare but documented)
• Cyclic vomiting syndrome: Recurrent episodes

4. Restrictive Eating and Malnutrition

• Anorexia nervosa: Severe caloric restriction with micronutrient depletion
• Hunger strikes: Documented in prison and political contexts
• Refugee populations: Food insecurity and monotonous diets
• Elderly with poor oral intake: Social isolation, dementia, dysphagia

5. Increased Metabolic Demand

• Hyperthyroidism: Increased metabolic rate
• Pregnancy and lactation: Increased nutritional requirements
• Malignancy: Tumor metabolism and cachexia
• Prolonged fever or infection: Increased metabolic demands

6. Iatrogenic and Medical

• Total parenteral nutrition without thiamine supplementation: Well-documented cause
• Dialysis: Can remove water-soluble vitamins including thiamine
• Diuretic therapy: Long-term use, particularly loop diuretics, increases urinary thiamine loss
• Prolonged fasting before emergency surgery: Particularly in already-malnourished patients

Thiamine Physiology and Depletion Kinetics

Thiamine is a water-soluble vitamin that cannot be synthesized by humans and must be obtained from dietary sources. Body stores are limited, approximately 30mg total, with a biological half-life of 9-18 days. In states of zero intake, stores are depleted within 4-6 weeks. [15,16]

Daily requirements:

• Adults: 1-1.5 mg/day
• Pregnancy/lactation: 1.4-1.5 mg/day
• Increased in: Fever, hyperthyroidism, high carbohydrate intake, dialysis

Dietary sources include whole grains, legumes, pork, beef, yeast, nuts. Refined carbohydrates (white rice, white bread) are thiamine-poor. Many countries have mandatory thiamine fortification of flour and cereals, which has reduced beriberi but not eliminated WKS in at-risk populations. [21]

---

3. Aetiology and Pathophysiology

Biochemical Basis of Thiamine Deficiency

Thiamine's Critical Metabolic Roles

Thiamine, in its active form thiamine pyrophosphate (TPP), serves as an essential cofactor for several key enzymes in carbohydrate metabolism and energy production: [15,16]

1. Pyruvate dehydrogenase complex: Converts pyruvate to acetyl-CoA for entry into the Krebs cycle
2. α-ketoglutarate dehydrogenase: Rate-limiting enzyme in the Krebs cycle
3. Transketolase: Key enzyme in the pentose phosphate pathway (important for NADPH and nucleotide synthesis)
4. Branched-chain α-keto acid dehydrogenase: Involved in amino acid metabolism

Pathophysiological Cascade

When thiamine becomes deficient, a cascade of metabolic failures ensues:

1. Impaired Oxidative Metabolism

• Pyruvate cannot be converted to acetyl-CoA efficiently
• Cells cannot generate adequate ATP via oxidative phosphorylation
• Tissues with high metabolic demand are most vulnerable (brain, heart, peripheral nerves)

2. Shift to Anaerobic Metabolism

• Accumulation of pyruvate and lactate
• Lactic acidosis in severe cases
• Reduced ATP generation exacerbates cellular dysfunction

3. Excitotoxicity and Oxidative Stress

• Reduced pentose phosphate pathway activity decreases NADPH
• NADPH is critical for glutathione synthesis and antioxidant defense
• Oxidative stress leads to lipid peroxidation and membrane damage
• Accumulation of excitatory neurotransmitters (particularly glutamate) causes neuronal injury [22]

4. Selective Neuronal Vulnerability

Specific brain regions are preferentially affected due to their high metabolic demands and unique vulnerabilities: [1,2,22]

Highly Vulnerable Areas (Wernicke's Encephalopathy):

• Mammillary bodies: Memory processing, part of Papez circuit
• Medial thalamus (particularly dorsomedial nucleus): Cognition and memory
• Periaqueductal gray: Oculomotor control
• Tectal plate (superior colliculi): Eye movement coordination
• Cerebellar vermis: Gait and truncal stability

Mechanism of Regional Selectivity:

• Higher baseline metabolic activity
• Greater density of thiamine-dependent enzymes
• Increased susceptibility to excitotoxic injury
• Blood-brain barrier characteristics that make them vulnerable to edema

Neuropathological Changes

Acute Phase (Wernicke's Encephalopathy)

Macroscopic findings:

• Petechial hemorrhages in periventricular regions
• Swelling and discoloration of mammillary bodies
• Edema in periaqueductal gray matter

Microscopic findings: [1,9]

• Neuronal loss and gliosis
• Capillary proliferation and endothelial swelling
• Hemorrhage and hemosiderin deposition
• Relative preservation of neuronal architecture in early stages (potentially reversible)

Chronic Phase (Korsakoff's Syndrome)

Macroscopic findings:

• Atrophy of mammillary bodies (often visible on MRI)
• Thalamic atrophy (particularly dorsomedial nucleus)
• Generalized cerebral atrophy (in severe cases)

Microscopic findings: [3,4]

• Neuronal loss (irreversible)
• Gliosis (astrocytic scarring)
• Hemosiderin deposits (evidence of previous hemorrhage)
• Loss of normal architecture

The transition from acute WE to chronic KS represents progression from edema and metabolic dysfunction (reversible) to actual neuronal death (irreversible). This underscores the critical importance of early recognition and treatment.

Cardiac and Peripheral Manifestations (Beriberi Spectrum)

While this topic focuses on the central nervous system manifestations (WKS), thiamine deficiency also causes:

Wet Beriberi (Cardiac): [28]

• High-output cardiac failure
• Peripheral edema
• Tachycardia, dyspnea
• Can coexist with WE
• Responds rapidly to thiamine replacement

Dry Beriberi (Peripheral Nerves):

• Symmetric peripheral neuropathy
• Distal sensory and motor deficits
• Reduced ankle reflexes
• Often present alongside WE in chronic alcoholics

The term "beriberi" is often reserved for peripheral and cardiac manifestations, while "Wernicke-Korsakoff" specifically denotes CNS involvement, though they represent a spectrum of the same deficiency state. [21]

---

4. Clinical Presentation

Wernicke's Encephalopathy (Acute Phase)

Classic Triad (Present in Only 10-16% of Cases) [13,14]

1. Ocular abnormalities
2. Ataxia
3. Confusion

Critical Point: The classic triad has poor sensitivity. Most patients present with incomplete or atypical features. Clinical diagnosis requires a high index of suspicion based on risk factors and context.

Caine Criteria (Operational Diagnostic Criteria)

Diagnosis requires 2 of 4 features: [13,14]

1. Dietary deficiency: Evidence of poor nutrition or alcohol dependence
2. Oculomotor abnormalities: Nystagmus, ophthalmoplegia, or gaze palsy
3. Cerebellar dysfunction: Ataxia or gait disturbance
4. Altered mental state or memory impairment: Confusion, disorientation, or cognitive deficits

The Caine criteria improve diagnostic sensitivity from 16% (classic triad) to approximately 85% in autopsy-validated studies.

Detailed Clinical Features

1. Ocular Manifestations (29-85% of cases) [2,14]

Most common (and often earliest sign):

• Horizontal nystagmus: Most frequent finding, may be the only ocular sign
• Lateral rectus (CN VI) palsy: Unilateral or bilateral, causes failure of lateral gaze
• Conjugate gaze palsy: Horizontal gaze palsy most common
• Vertical nystagmus: Less common, suggests more extensive brainstem involvement

Less common but indicating severe disease:

• Complete ophthalmoplegia (all eye movements lost)
• Ptosis
• Pupillary abnormalities (sluggish or unequal)
• Retinal hemorrhages (rare)

Clinical Pearl: Eye signs may respond within hours of IV thiamine administration, often before other features improve. Resolution of ophthalmoplegia within 24 hours of thiamine is considered pathognomonic for WE.

2. Ataxia (23-70% of cases) [2,13]

• Gait ataxia: Wide-based, unsteady gait; may be unable to stand without support
• Truncal ataxia: Difficulty sitting upright
• Limb ataxia: Less prominent than gait ataxia
• Vestibular component: May have vertigo or nystagmus-induced oscillopsia

The ataxia is cerebellar in origin (vermis involvement), not sensory. Romberg test may be positive but is not discriminatory. Heel-to-shin and finger-to-nose testing may show dysmetria.

3. Altered Mental Status (82-90% of cases) [2,13]

Spectrum of severity:

• Mild: Apathy, inattention, poor concentration
• Moderate: Confusion, disorientation (time, place), anterograde amnesia
• Severe: Stupor, coma (indicates brainstem involvement, grave prognosis)

Characteristic pattern:

• Global confusional state: Rather than focal cognitive deficit
• Preserved consciousness initially (not obtunded unless severe)
• Disorientation: Particularly to time and place
• Anterograde amnesia: Cannot form new memories (early sign of progression to KS)

Associated features:

• Apathy and lack of spontaneous speech
• Slowed mentation (bradyphrenia)
• Poor attention span
• Indifference to surroundings (may be misattributed to alcohol intoxication)

4. Autonomic Dysfunction (Often Overlooked)

• Hypothermia: Hypothalamic involvement [23]
• Hypotension: Orthostatic hypotension common
• Tachycardia: May be unexplained
• Pupillary abnormalities: Sluggish light response

Red Flag: Unexplained hypothermia in an alcoholic or malnourished patient should trigger immediate consideration of WE.

5. Other Neurological Features

• Peripheral neuropathy: Co-existing "dry beriberi" in up to 80% of alcoholics with WE
• Seizures: Rare in pure WE, but alcohol withdrawal seizures may co-occur
• Hearing loss: Rare but documented

Clinical Phenotypes and Presentations

1. Hyperacute Presentation

• Rapid onset over hours to days
• Often precipitated by glucose administration without thiamine
• Profound confusion, ophthalmoplegia, severe ataxia
• Risk of rapid progression to coma and death

2. Chronic/Subacute Presentation

• Insidious onset over weeks
• Mild cognitive impairment and gait instability
• May be mistaken for dementia or chronic alcoholism effects
• Often only recognized in retrospect after thiamine trial

3. "Wet Brain" Crisis

• Acute decompensation in chronic alcoholic
• Precipitated by intercurrent illness, surgery, or nutritional stress
• May present as unexplained delirium or "failure to thrive"

Korsakoff's Syndrome (Chronic Phase)

Korsakoff's syndrome develops in approximately 80% of patients with untreated or inadequately treated WE. It may develop acutely after WE or insidiously without a clear acute phase. [3,4]

Core Features

1. Anterograde Amnesia (Defining Feature)

• Profound inability to form new memories: Retention time typically less than 5 minutes
• Immediate recall intact (can repeat a 7-digit number) but no consolidation
• Patient cannot recall events from minutes ago
• Unable to learn new names, faces, locations
• Cannot remember conversations, meals, visits
• Prevents independent living

Testing:

• Ask patient to remember 3 objects; test recall at 5 minutes (will fail)
• Ask about events from earlier in the day (no recollection)
• Ask patient to describe route to bathroom (visited multiple times) – cannot do it

2. Retrograde Amnesia

• Variable loss of past memories
• Temporal gradient: Recent past more affected than distant past (Ribot's law)
• Remote memories (childhood, early adulthood) often relatively preserved
• Personal identity usually intact

3. Confabulation (60-80% of cases)

• Definition: Fabrication of events to fill memory gaps without intent to deceive
• Patient genuinely believes the false memories
• Content may be plausible or bizarre
• Provoked: Emerges when memory questioned
• Spontaneous: Rare, indicates more severe pathology

Example: Asked "What did you have for breakfast?", patient may give detailed description of a meal that never occurred, or describe breakfast from years ago as if it happened today.

Clinical Pearl: Confabulation is not lying. The patient lacks insight into their memory deficit and the brain generates false memories to maintain narrative coherence.

4. Lack of Insight (Anosognosia)

• Patients typically unaware of memory deficits
• May deny any problem when confronted
• Prevents cooperation with treatment and rehabilitation
• Major barrier to safety and independent living

5. Apathy and Affective Blunting

• Lack of emotional response
• Reduced motivation and initiative
• Emotional indifference to memory deficits
• May appear "pleasantly confused"

Preserved Functions in Korsakoff's Syndrome

Despite profound amnesia, several cognitive domains remain relatively intact:

• Immediate memory: Can repeat sequences immediately
• Remote memory: Childhood and early life memories preserved
• Semantic memory: General knowledge relatively preserved
• Procedural memory: Can learn new motor skills (though won't remember learning them)
• Implicit learning: Some learning without conscious awareness
• Language: Intact grammar, vocabulary, fluency

This pattern of preserved and impaired functions reflects the specific neuroanatomy (mammillary bodies and dorsomedial thalamus critical for declarative memory encoding).

Functional Impact

• Employment: Impossible due to inability to learn new information
• Independent living: Not safe (cannot remember appointments, medications, safety instructions)
• Relationships: Severely impaired (cannot remember recent interactions with loved ones)
• Institutionalization: Required in approximately 75-80% of cases [4]

Prognosis: Only 20% show significant recovery of memory function. Most require lifelong supervised care. Recovery, if it occurs, is typically partial and may take months to years. Recent case reports demonstrate that aggressive high-dose thiamine (up to 600 mg/day oral plus 300 mg/day IM) may produce complete recovery even after prolonged symptoms, though this remains exceptional. [3,4,29]

---

5. Differential Diagnosis

The presentation of WE is non-specific and overlaps with many acute and chronic neurological conditions. Maintaining a high index of suspicion based on risk factors is critical.

Acute Confusional States

Chronic Cognitive Impairment

Ataxia Syndromes

Ocular Motor Disorders

Must-Not-Miss Diagnoses

These conditions require urgent specific management:

1. Hypoglycaemia: Bedside glucose test essential in all patients with altered consciousness
2. Bacterial meningitis: Fever, headache, neck stiffness warrant LP and antibiotics
3. Subdural hematoma: Trauma history (may be remote); CT shows collection
4. Carbon monoxide poisoning: History of exposure; carboxyhaemoglobin level
5. Opioid toxicity: Pinpoint pupils; respiratory depression; responds to naloxone

Clinical Approach: In at-risk populations (alcoholic, malnourished), empirical thiamine should be given even when alternative diagnoses are being pursued, as it is low-risk and potentially life-saving.

---

6. Investigations

General Principle: Diagnosis is Clinical – Do Not Delay Treatment

Wernicke's encephalopathy is a clinical diagnosis. Treatment with IV thiamine should be initiated immediately based on clinical suspicion, without waiting for confirmatory investigations. [7,8]

Thiamine Assays (Limited Utility in Acute Setting)

1. Erythrocyte Transketolase Activity

• Measures functional thiamine status
• Gold standard biochemical test for chronic deficiency
• Requires specialized laboratory; results take days to weeks
• Not useful for acute diagnosis
• Activation coefficient > 25% indicates deficiency

2. Serum/Plasma Thiamine Levels

• Direct measurement of thiamine concentration
• Normal range: 70-180 nmol/L
• Poor correlation with tissue stores
• Results take days; limited availability
• Not useful for acute diagnosis

3. Whole Blood Thiamine

• Better reflects tissue stores than serum alone
• Still requires specialized lab; delayed results
• May be checked retrospectively to confirm deficiency

Clinical Reality: These tests are rarely obtained in acute practice and should never delay thiamine administration. They may be useful for confirming diagnosis retrospectively or in medico-legal contexts.

Neuroimaging

MRI Brain (Investigation of Choice)

Sensitivity: 50-85% depending on timing and sequence [24,25,27]

Optimal sequences: T2, FLAIR, DWI (diffusion-weighted imaging)

Classical Findings in Wernicke's Encephalopathy:

Highly specific locations:

1. Mammillary bodies: Bilateral symmetric T2/FLAIR hyperintensity with possible enhancement (most specific finding)
2. Medial thalami: Bilateral dorsomedial thalamic T2 hyperintensity
3. Periaqueductal gray: Hyperintensity surrounding cerebral aqueduct
4. Tectal plate: Superior and inferior colliculi involvement

Additional findings (less specific):

• Cerebellar vermis edema
• Hypothalamus
• Red nuclei
• Caudate nuclei

Timing considerations:

• Acute phase: Edema, T2/FLAIR hyperintensity, possible restricted diffusion (DWI)
• Subacute phase (days-weeks): Enhancement with gadolinium
• Chronic phase (Korsakoff's): Atrophy of mammillary bodies and thalami; resolution of hyperintensity

Advanced MRI Findings: [27]

• Diffusion tensor imaging (DTI) can detect microstructural changes before conventional MRI
• Susceptibility-weighted imaging (SWI) may show microhemorrhages
• MR spectroscopy shows reduced N-acetylaspartate (NAA) and elevated lactate

Sensitivity limitations:

• Normal MRI does not exclude WE (sensitivity only 50-85%)
• Early imaging (first 24-48 hours) may be normal
• Repeat imaging after 1-2 weeks may reveal evolving changes
• Chronic alcoholics may have background cerebral atrophy obscuring acute changes

MRI in Korsakoff's Syndrome:

• Mammillary body atrophy (very specific)
• Thalamic atrophy (dorsomedial nuclei)
• Generalized cerebral atrophy
• No acute signal changes (chronic changes only)

CT Brain (Limited Sensitivity)

• Poor sensitivity for WE (approximately 10-20%)
• May show mammillary body or thalamic hypodensity in severe cases
• Useful to exclude alternative diagnoses (hemorrhage, mass lesion)
• Should not be relied upon to diagnose or exclude WE

Role of CT: In emergency setting, CT may be performed to exclude stroke or hemorrhage, but normal CT does not exclude WE. Proceed with empirical thiamine based on clinical suspicion.

Routine Laboratory Investigations

These do not diagnose WE but guide management and identify complications:

Essential Tests:

Additional Tests Based on Context:

• Beta-HCG: If female of reproductive age (pregnancy-related WE)
• Thyroid function: Hyperthyroidism increases thiamine demand
• Toxicology screen: Co-ingestants, drug use
• Blood alcohol level: Confirms recent alcohol use
• Inflammatory markers: If sepsis suspected

Electroencephalography (EEG)

• Non-specific findings: Diffuse slowing (theta and delta activity)
• Useful to exclude non-convulsive status epilepticus
• Not diagnostic for WE

Cognitive Assessment

Acute Phase (WE):

• Formal testing often not feasible due to confusional state
• Abbreviated Mental Test Score (AMTS) or Mini-Mental State Examination (MMSE) shows global impairment
• Document baseline for comparison post-treatment

Chronic Phase (KS):

• Detailed neuropsychological testing reveals:
  • Profound anterograde amnesia
  • Variable retrograde amnesia
  • Preserved immediate recall
  • Preserved IQ and semantic knowledge
  • Executive dysfunction variable

Useful tests:

• Montreal Cognitive Assessment (MoCA): Sensitive to memory impairment
• Rey Auditory Verbal Learning Test: Anterograde memory
• Autobiographical Memory Interview: Retrograde memory
• Wechsler Memory Scale: Comprehensive memory assessment

---

7. Management

Emergency Management Principles

1. Thiamine BEFORE Glucose 2. High-dose Intravenous Thiamine 3. Magnesium Replacement 4. Supportive Care and Monitoring

Acute Management of Suspected Wernicke's Encephalopathy

Immediate Actions (First Hour)

1. Clinical Assessment

• Rapid history: Alcohol use, dietary history, vomiting, weight loss, recent surgery
• Focused examination: Eye movements, gait, cognitive state, signs of malnutrition
• Vital signs: Temperature (hypothermia?), BP (hypotension?), HR

2. Investigations

• Bedside glucose (before any IV dextrose)
• Blood tests: FBC, U&Es (including magnesium), LFTs, glucose, B12/folate, coagulation
• Consider: MRI brain (if diagnosis uncertain, but do not delay thiamine)

3. Immediate Thiamine Administration

Do not wait for:

• MRI results
• Thiamine levels
• Confirmatory investigations

Rationale: Thiamine is safe, deficiency is potentially fatal, and delay risks irreversible brain damage.

Thiamine Regimens

UK Guideline (Royal College of Physicians / NICE): [7,8]

Pabrinex I.V. High Potency (Preferred in UK)

• Contents per pair of ampoules:
  • "Ampoule 1 (5 mL): Thiamine 250 mg, Riboflavin 4 mg, Pyridoxine 50 mg"
  • "Ampoule 2 (5 mL): Ascorbic acid 500 mg, Nicotinamide 160 mg"
• Administration: Both ampoules diluted in 50-100 mL normal saline or 5% dextrose, infused over 30 minutes

Dosing Schedules:

Alternative Regimens (Where Pabrinex Unavailable):

IV Thiamine Hydrochloride:

• Dose: 200-500 mg intravenously
• Frequency: Three times daily
• Dilution: In 50-100 mL normal saline over 30 minutes

Intramuscular Thiamine:

• Less reliable absorption
• Reserved for when IV access not available
• Dose: 250 mg IM once or twice daily

United States Guidelines (American Academy of Neurology): [26]

• IV thiamine 500 mg three times daily for 3-5 days
• Then oral thiamine 100-250 mg three times daily

Anaphylaxis Risk and Precautions

Incidence: Anaphylaxis to Pabrinex is extremely rare (estimated 1 in 250,000 doses) [7]

Precautions:

• Resuscitation facilities should be available (standard in hospitals)
• Observe patient during first infusion
• Do not delay treatment due to anaphylaxis concerns
• Risk-benefit strongly favors treatment

Contraindication: None in context of suspected WE (benefits vastly outweigh risks)

Magnesium Replacement

Rationale: Magnesium is required for conversion of thiamine to its active form (thiamine pyrophosphate). Hypomagnesaemia is present in up to 80% of chronic alcoholics and impairs thiamine efficacy. [17]

Target: Serum magnesium > 0.85 mmol/L (> 2.0 mg/dL)

Regimens:

Monitoring: Recheck magnesium daily; adjust replacement accordingly

Caution: Avoid rapid IV bolus (risk of arrhythmia); infuse slowly. Reduce dose in renal impairment.

Glucose Management

The Critical Rule: Thiamine Before Dextrose

If Hypoglycaemic:

1. Give Pabrinex or IV thiamine first (or simultaneously)
2. Then give IV dextrose (50 mL of 50% dextrose or 100 mL of 10% dextrose)

If Normoglycaemic:

• Avoid unnecessary glucose administration
• If IV fluids required, use normal saline initially
• Once thiamine on board, dextrose-containing fluids are safe

Rationale: Glucose metabolism consumes thiamine. In a thiamine-deficient patient, a glucose load can precipitate acute WE or worsen existing deficiency ("biochemical steal").

Supportive Care

1. Refeeding Syndrome Prevention

At-risk patients (malnourished, alcoholic, prolonged fasting) require:

• Thiamine: As above (also prevents refeeding-associated WE)
• Phosphate: Monitor and replace (target > 0.8 mmol/L)
• Potassium: Monitor and replace (target > 4.0 mmol/L)
• Magnesium: As above
• Slow reintroduction of calories: Start 25-50% of estimated requirements; increase gradually over 4-7 days
• Daily monitoring: U&Es, magnesium, phosphate for first week

2. Alcohol Withdrawal Management

If patient is alcohol-dependent, assess for and manage withdrawal:

• CIWA-Ar score to quantify severity
• Benzodiazepines: Chlordiazepoxide or lorazepam as per protocol
• Monitor for delirium tremens: Can coexist with WE
• Seizure prophylaxis: Adequate benzodiazepines

3. Nutrition

• Enteral nutrition preferred (oral or NG tube)
• Multivitamin supplementation: B complex, vitamin C
• Avoid parenteral nutrition initially unless essential (risk of refeeding)
• Dietitian review: Assess nutritional requirements

4. General Supportive Measures

• Hydration: IV fluids if poor oral intake (normal saline initially)
• Prevention of complications: DVT prophylaxis, pressure area care, fall prevention
• Monitoring: Vital signs, GCS, fluid balance
• Treat intercurrent illness: Infections, electrolyte imbalances

Monitoring Response to Treatment

Expected Time Course: [2,7]

Indicators of Good Response:

• Improvement in eye movements within 24-48 hours
• Clearing of confusion over days
• Improved gait stability

Indicators of Poor Prognosis:

• No improvement in ocular signs after 48 hours of treatment
• Progression to stupor or coma
• Development of profound amnesia (progression to KS)

Transition to Oral Thiamine

When to Transition:

• After 3-5 days of IV therapy
• Clinical improvement plateaued
• Patient able to take oral medication
• No ongoing vomiting

Oral Dose:

• Thiamine 100 mg three times daily
• Continue indefinitely if continued alcohol use
• May reduce to 100 mg once daily after abstinence established

Limitations of Oral Thiamine:

• Poor absorption in active alcoholics (intestinal edema, gastritis, impaired active transport)
• Inadequate for acute treatment
• Useful for maintenance and prophylaxis

Management of Korsakoff's Syndrome

Once established, Korsakoff's syndrome is largely irreversible. Management is supportive and rehabilitative.

Pharmacological

Continue Thiamine:

• Oral thiamine 100 mg TDS indefinitely
• May prevent further deterioration
• Minimal benefit for established amnesia

Treat Co-Morbidities:

• Manage alcohol dependence (if applicable)
• Treat depression, anxiety (common)
• Manage behavioral disturbances if present

No Specific Pharmacological Treatment for Amnesia:

• Cholinesterase inhibitors (donepezil, rivastigmine): No proven benefit
• Memantine: No proven benefit
• Other cognitive enhancers: No evidence base

Non-Pharmacological

1. Environmental Modification

• Structured, predictable environment
• Memory aids: Written schedules, labels, calendars
• Reduce distractions and confusion

2. Cognitive Rehabilitation

• Errorless learning techniques: Prevent encoding of errors
• Spaced retrieval training: Gradual expansion of recall intervals
• External memory aids: Notebooks, electronic reminders
• Reality orientation: Regular reminders of date, place, situation

3. Behavioral Management

• Manage confabulation without confrontation (challenging false memories causes distress)
• Redirect rather than correct
• Maintain dignity and respect

4. Placement

• Most patients require long-term supervised care (75-80%)
• Options: Specialist nursing home, alcohol rehabilitation unit, psychiatric facility
• Home care possible only with intensive family/caregiver support

5. Family Support and Education

• Realistic prognostic counseling (only 20% significant recovery)
• Education about memory deficits and confabulation
• Caregiver support and resources
• Advance care planning and lasting power of attorney considerations

---

8. Complications

Complications of Untreated or Inadequately Treated Wernicke's Encephalopathy

Complications of Treatment

Anaphylaxis to Pabrinex:

• Incidence: 1 in 250,000 [7]
• Management: Standard anaphylaxis protocol (IM adrenaline, IV fluids, antihistamines, corticosteroids)
• Prevention: Have resuscitation facilities available; observe during infusion

Refeeding Syndrome:

• Incidence: High in malnourished patients receiving aggressive refeeding
• Features: Hypophosphatemia, hypokalemia, hypomagnesemia, fluid overload, cardiac failure
• Prevention: Slow reintroduction of calories; aggressive electrolyte monitoring and replacement
• Management: Reduce caloric intake; aggressive electrolyte replacement; monitor cardiac function

Alcohol Withdrawal Complications (if co-existing):

• Delirium tremens
• Withdrawal seizures
• Arrhythmias
• Hyperthermia
• Management: Benzodiazepines; supportive care

Long-Term Complications in Korsakoff's Syndrome

Medical:

• Continued alcohol use (if not abstinent): Liver disease, pancreatitis, malignancy
• Falls: Due to ataxia and cognitive impairment
• Aspiration pneumonia: Reduced awareness and safety
• Pressure ulcers: In institutionalized patients

Psychosocial:

• Inability to work: Due to profound amnesia
• Loss of independence: Requires supervised living
• Social isolation: Loss of relationships due to memory deficits
• Caregiver burden: Family stress and burnout

Medicolegal:

• Loss of capacity: Inability to make decisions
• Need for guardianship/power of attorney
• Ethical issues: Consent for treatment, end-of-life planning

---

9. Prognosis and Outcomes

Wernicke's Encephalopathy

Mortality:

• Untreated: 17-20% [1,2]
• Treated promptly: less than 5%
• Death usually due to brainstem involvement, aspiration, sepsis, or cardiovascular collapse

Recovery Trajectory with Treatment: [2,7]

Ocular Signs:

• Improvement typically begins within hours to days
• Ophthalmoplegia may resolve completely within 1-2 weeks
• Nystagmus often persists (50% have residual nystagmus)

Ataxia:

• Improvement over weeks to months
• Complete recovery in approximately 40%
• Partial recovery in 40%
• Persistent ataxia in 20%

Confusion and Cognitive Impairment:

• Improvement over days to weeks
• Complete cognitive recovery: 20-25%
• Mild residual deficits: 25%
• Progression to Korsakoff's syndrome: 50-80% (depending on treatment timing and adequacy)

Predictors of Poor Outcome:

• Delayed treatment (> 48-72 hours after symptom onset)
• Inadequate thiamine dosing (oral only, or low-dose IV)
• Severe presenting features (coma, complete ophthalmoplegia)
• Recurrent episodes
• Continued alcohol use
• Co-existing liver disease or malnutrition

Korsakoff's Syndrome

Recovery:

• Significant recovery of memory function: 20%
• Partial improvement: 25-30%
• No improvement: 50-55% [3,4]

Recovery, when it occurs:

• Takes months to years
• Usually incomplete
• Best outcomes seen with:
  • Early and adequate thiamine treatment
  • Abstinence from alcohol
  • Structured rehabilitation
  • Young age

Long-Term Outcomes:

• Independent living: Possible in less than 25%
• Institutional care required: 75-80%
• Return to employment: Rare (less than 10%)
• 5-year survival: Approximately 50-60% (reduced by continued alcohol use, liver disease, comorbidities) [30]
• Median survival: Studies show poor long-term mortality, with death often from liver disease, infection, or cardiovascular causes

Prognostic Factors for KS:

Recurrence Risk

Relapse of WE:

• High risk if:
  • Return to alcohol use without thiamine supplementation
  • Recurrent vomiting or malnutrition
  • Non-compliance with oral thiamine
• Prevention:
  • Long-term oral thiamine (100 mg TDS)
  • Alcohol cessation support
  • Nutritional counseling
  • Regular medical follow-up

Secondary Prevention:

• All patients with previous WE should receive prophylactic IV thiamine during any future hospital admission
• Document history prominently in medical records
• Patient should carry medical alert card/bracelet

---

10. Prevention and Screening

Primary Prevention (Population Level)

Food Fortification:

• Mandatory thiamine fortification of flour and cereals in many countries
• Has reduced prevalence of beriberi but not eliminated WKS in at-risk groups
• Advocated as public health measure [21]

Alcohol Policy:

• Public health measures to reduce harmful alcohol consumption
• Early identification and support for alcohol use disorder

Secondary Prevention (High-Risk Groups)

Alcohol Use Disorder:

• NICE Guideline CG100 [8]: Offer prophylactic oral thiamine to harmful/dependent drinkers in community
  • Oral thiamine 200-300 mg daily (in divided doses)
  • Continue as long as harmful drinking persists
• Prophylactic IV thiamine for all alcohol-dependent patients admitted to hospital:
  • 1 pair Pabrinex IV daily for 3-5 days
  • Higher threshold for treatment than for harm

Pre-Operative Assessment:

• Identify malnourished or at-risk patients before elective surgery
• Provide thiamine supplementation pre-operatively
• Avoid prolonged fasting without nutritional support

Hyperemesis Gravidarum:

• Early identification of severe vomiting in pregnancy
• Oral thiamine 25-50 mg TDS for all women with hyperemesis [11]
• IV thiamine if:
  • Persistent vomiting > 3 weeks
  • Weight loss > 5 kg
  • Ketonuria
  • Any neurological symptoms
• Do not wait for neurological signs to develop

Post-Bariatric Surgery:

• Routine thiamine supplementation for all post-bariatric patients
• Oral thiamine 50-100 mg daily indefinitely
• Monitor for symptoms of deficiency
• Immediate IV thiamine if vomiting or neurological symptoms [20]

Parenteral Nutrition:

• All TPN formulations must include thiamine
• Standard adult dose: 100-200 mg daily in TPN
• Higher doses if deficiency suspected or at high risk
• Monitor thiamine status in long-term TPN

Oncology Patients:

• Assess nutritional status in all cancer patients
• Prophylactic thiamine for those with persistent vomiting from chemotherapy
• Consider IV thiamine if poor oral intake or vomiting

Tertiary Prevention (Preventing Recurrence)

After Acute WE Episode:

• Oral thiamine 100 mg TDS indefinitely (or until alcohol abstinence well-established)
• Document WE history prominently in medical records
• Medical alert: Patient should carry card/bracelet indicating WE history
• Alcohol cessation support: Referral to addiction services
• Nutritional counseling: Dietitian input
• Regular follow-up: Monitor compliance, alcohol use, nutritional status

Future Hospital Admissions:

• Any patient with previous WE should receive prophylactic IV thiamine during admissions
• Even if asymptomatic
• Prevents recurrence triggered by fasting, surgery, or intercurrent illness

---

11. Guidelines and Evidence Base

Key Guidelines

Landmark Evidence

Caine Criteria Validation (Harper et al., 1986): [13]

• Autopsy study of 131 cases
• Classic triad present in only 16%
• Caine criteria (2 of 4 features) sensitivity 85%
• Established operational diagnostic criteria still used today

Thomson et al. (2002) - Royal College of Physicians Report: [7]

• Systematic review of thiamine dosing
• Established inadequacy of oral thiamine for acute WE
• Recommended IV high-dose regimen (Pabrinex 2-3 pairs TDS)
• Formed basis for UK guidelines

Harper et al. (1998) - Autopsy Study: [9]

• 131 autopsy-confirmed cases of WE
• Only 20% diagnosed clinically
• 80% under-diagnosis rate
• Highlighted massive clinical under-recognition

Sechi and Serra (2007) - Systematic Review: [1]

• Comprehensive review of WE pathophysiology, diagnosis, treatment
• Emphasized need for high index of suspicion
• Detailed neuroimaging findings
• Highlighted non-alcoholic causes

Isenberg-Grzeda et al. (2012) - Hyperemesis Review: [11]

• Systematic review of WE in hyperemesis gravidarum
• Median time to WE: 5 weeks of vomiting
• Emphasized need for early thiamine supplementation in severe hyperemesis
• Medicolegal implications of missed diagnosis

Oudman et al. (2021) - Korsakoff's Outcome: [4]

• Long-term follow-up study
• Only 20% significant recovery
• 75-80% require long-term institutional care
• Emphasized poor prognosis of established KS

Controversies and Evolving Evidence

Optimal Thiamine Dose:

• No RCTs comparing dosing regimens (unlikely to ever be conducted due to ethical issues)
• Current recommendations based on case series and expert consensus
• Some advocate even higher doses (500 mg TDS IV) in severe cases
• General agreement that higher doses are safe and likely more effective

Route and Duration:

• Consensus: IV route essential for acute WE
• Oral absorption inadequate in alcoholics (intestinal pathology)
• Duration: Continue until improvement plateaus (typically 3-5 days, sometimes longer)

Anaphylaxis Risk:

• Historical concerns about Pabrinex anaphylaxis have been overemphasized
• True incidence extremely low (1 in 250,000)
• Risk-benefit analysis strongly favors treatment
• Some clinicians still hesitate due to unfounded concerns

MRI Sensitivity:

• Recognized that MRI is not 100% sensitive
• Normal MRI does not exclude WE
• Diagnosis remains clinical
• MRI useful for confirmation and excluding differentials

Prevention in At-Risk Groups:

• Growing evidence for prophylactic thiamine in non-alcoholic at-risk groups
• Routine supplementation in bariatric surgery, hyperemesis, oncology increasingly standard
• Cost-effectiveness arguments support broader supplementation

---

12. Special Populations

Pregnancy and Hyperemesis Gravidarum

Risk: Prolonged vomiting (typically > 3 weeks) in pregnancy depletes thiamine stores, precipitating WE. [11,12]

Incidence: Estimated 0.04-0.13% of severe hyperemesis cases develop WE (likely underestimate)

Clinical Features:

• Onset typically 5-8 weeks after vomiting begins
• Classical WE triad uncommon
• Confusion, ataxia, visual disturbance in context of prolonged vomiting

Management:

• Low threshold for thiamine supplementation:
  • "All women with hyperemesis: Oral thiamine 25-50 mg TDS"
  • "Severe hyperemesis (persistent > 3 weeks, weight loss > 5 kg, ketonuria): Consider IV thiamine prophylactically"
  • "Any neurological symptoms: Immediate IV thiamine (Pabrinex 2-3 pairs TDS)"
• Do not wait for diagnostic confirmation
• MRI safe in pregnancy (no gadolinium unless essential)
• Early involvement of obstetrics, neurology, nutrition

Fetal Considerations:

• Thiamine crosses placenta; maternal deficiency affects fetus
• Thiamine supplementation safe in pregnancy (water-soluble, no teratogenicity)
• IV thiamine does not harm fetus
• Risk of maternal WE vastly outweighs any theoretical risks

Medicolegal:

• Missed WE in hyperemesis is a significant cause of litigation
• Document thiamine supplementation clearly
• Low threshold for escalation

Post-Bariatric Surgery

Risk: Rapid weight loss, reduced food intake, malabsorption (especially Roux-en-Y gastric bypass which bypasses thiamine absorption site in duodenum). [20]

Timing: Highest risk in first 6-12 months post-surgery

Clinical Features:

• May present atypically
• Vomiting is red flag (common post-bariatric complication)
• Peripheral neuropathy often co-exists

Prevention:

• Routine lifelong thiamine supplementation post-bariatric surgery:
  • Oral thiamine 50-100 mg daily minimum
  • Higher doses if vomiting or poor intake
• Immediate IV thiamine if:
  • Persistent vomiting
  • Neurological symptoms
  • Rapid unintended weight loss

Management:

• IV thiamine as per standard WE protocol
• Investigate and treat cause of vomiting (stricture, marginal ulcer, etc.)
• Long-term monitoring for nutritional deficiencies

Oncology Patients

Risk: Malnutrition (tumor cachexia), chemotherapy-induced vomiting, reduced oral intake.

Recognition:

• Often attributed to chemotherapy side effects or metastatic disease
• High index of suspicion required
• Confusion may be mistaken for brain metastases or medication side effects

Management:

• Prophylactic thiamine for patients with prolonged vomiting or poor intake
• Immediate IV thiamine if neurological signs
• Nutritional support and anti-emetics

Elderly

Risk: Poor dietary intake, social isolation, multiple comorbidities, polypharmacy (diuretics).

Clinical Features:

• Often atypical presentation
• Confusion may be attributed to dementia
• Falls due to ataxia

Management:

• High index of suspicion in elderly with unexplained confusion or falls
• Screen for malnutrition and vitamin deficiencies
• Social support and nutritional supplementation

Dialysis Patients: [31]

• Chronic hemodialysis can deplete thiamine (water-soluble vitamin lost during dialysis)
• CNS symptoms in dialysis patients warrant thiamine supplementation
• Routine monitoring and supplementation recommended

Critical Care Patients: [32]

• Prevalence of thiamine deficiency in ICU may be as high as 20%
• Multiple risk factors: NPO status, hypermetabolic states, diuresis, sepsis
• Low threshold for empirical thiamine in critically ill with altered mental status
• Prophylactic supplementation increasingly recommended

Drug-Induced Thiamine Antagonism: [33]

• Metronidazole can function as thiamine antagonist
• Furosemide and other loop diuretics increase urinary thiamine loss
• Chemotherapy agents (5-FU, ifosfamide) increase thiamine requirements
• Consider prophylactic thiamine in patients on these medications

Eating Disorders (Anorexia Nervosa)

Risk: Severe caloric restriction, purging behaviors (vomiting, laxatives).

Recognition:

• Often young females
• Refeeding context particularly high risk
• Psychiatric comorbidity may complicate diagnosis

Management:

• Thiamine supplementation before and during refeeding
• Monitor for refeeding syndrome
• Multidisciplinary approach (psychiatry, nutrition, medicine)
• WE prevention guidelines specific to anorexia nervosa now exist [34]

---

13. Examination Focus

Common MRCP/Neurology Exam Scenarios

1. SAQ: "A 55-year-old man with a history of alcohol dependence presents to the Emergency Department with confusion. Blood glucose is 2.8 mmol/L. Outline your immediate management."

Model Answer:

• "I would immediately administer Pabrinex IV (2 pairs of ampoules) diluted in 100 mL saline and infused over 30 minutes."
• "Simultaneously or immediately after, I would give IV dextrose (50 mL of 50% dextrose or 100 mL of 10% dextrose) to correct hypoglycemia."
• "The critical principle is thiamine before glucose, as giving glucose to a thiamine-deficient patient can precipitate or worsen Wernicke's encephalopathy by consuming remaining thiamine stores."
• "I would also check serum magnesium and replace aggressively (target > 0.85 mmol/L), as magnesium is required for thiamine to function."
• "I would monitor for alcohol withdrawal and provide supportive care."

2. PACES Station: "This 60-year-old man has been brought in by ambulance. Please examine his eyes and nervous system."

Findings:

• Horizontal nystagmus on lateral gaze
• Bilateral lateral rectus palsy (CN VI)
• Wide-based ataxic gait
• Disorientation to time and place
• Stigmata of chronic liver disease

Presentation:

• "This gentleman has horizontal nystagmus, bilateral sixth nerve palsies, and gait ataxia, in the context of chronic alcohol use. This constellation of findings is highly suggestive of Wernicke's encephalopathy."
• "I would immediately arrange for high-dose intravenous Pabrinex (2-3 pairs TDS) without waiting for investigations."
• "I would check blood glucose before giving any dextrose, and ensure adequate magnesium replacement."
• "I would arrange urgent MRI brain to confirm the diagnosis, looking for T2 hyperintensity in the mammillary bodies, medial thalami, and periaqueductal gray matter."

3. Viva: "What is the Caine criteria and why is it used?"

Model Answer:

• "The Caine criteria are operational diagnostic criteria for Wernicke's encephalopathy, requiring 2 out of 4 features:"
  • "1. Dietary deficiency or alcohol dependence"
  • "2. Oculomotor abnormalities (nystagmus, ophthalmoplegia, gaze palsy)"
  • "3. Cerebellar dysfunction (ataxia)"
  • "4. Altered mental state or memory impairment"
• "The classic triad of confusion, ataxia, and ophthalmoplegia is only present in 10-16% of cases, meaning reliance on it misses the majority of patients."
• "The Caine criteria have much higher sensitivity (approximately 85% in autopsy-validated studies) and are therefore preferred for clinical diagnosis."
• "The criteria emphasize that WE is a clinical diagnosis and treatment should not be delayed for investigations."

4. Viva: "Describe the neuropathology of Korsakoff's syndrome."

Model Answer:

• "Korsakoff's syndrome results from irreversible neuronal loss in specific brain structures critical for memory encoding, particularly the mammillary bodies and the dorsomedial nucleus of the thalamus."
• "These structures are part of the Papez circuit, which is essential for declarative memory formation."
• "The mammillary bodies receive input from the hippocampus via the fornix and project to the anterior thalamic nuclei via the mammillothalamic tract."
• "Damage to this circuit prevents the consolidation of new memories (anterograde amnesia) and disrupts retrieval of recent past memories (retrograde amnesia with temporal gradient)."
• "MRI in chronic Korsakoff's syndrome typically shows atrophy of the mammillary bodies and medial thalamic nuclei, distinguishing it from other causes of amnesia."
• "In contrast to Alzheimer's disease, the hippocampus is relatively preserved in Korsakoff's syndrome, which explains the preservation of immediate recall."

5. MCQ Stem: "A 28-year-old woman 8 weeks pregnant presents with confusion and unsteady gait. She has been vomiting daily for 5 weeks. What is the most appropriate immediate management?"

A. Oral thiamine 100 mg TDS B. MRI brain C. IV Pabrinex 2 pairs TDS D. IV dextrose E. Anti-emetics and IV fluids

Correct Answer: C

Explanation:

• This is Wernicke's encephalopathy secondary to hyperemesis gravidarum.
• Immediate high-dose IV thiamine (Pabrinex) is required.
• Oral thiamine (A) is inadequate for acute treatment.
• MRI (B) is useful for confirmation but should not delay treatment.
• IV dextrose (D) should only be given after thiamine (to avoid precipitating WE).
• Anti-emetics (E) are needed but do not address the acute neurological emergency.

Viva Preparation: Opening Statement

"Wernicke-Korsakoff syndrome is a neuropsychiatric disorder caused by thiamine (vitamin B1) deficiency. It encompasses two related entities: Wernicke's encephalopathy, an acute and potentially reversible neurological emergency characterized by confusion, ataxia, and oculomotor abnormalities; and Korsakoff's syndrome, a chronic and largely irreversible amnestic disorder characterized by profound anterograde amnesia and confabulation."

"While historically associated with chronic alcoholism, WKS can occur in any state of severe malnutrition or malabsorption, including hyperemesis gravidarum, post-bariatric surgery, and prolonged vomiting from any cause."

"Diagnosis is clinical, guided by the Caine criteria, and treatment must be initiated immediately with high-dose intravenous thiamine, without waiting for confirmatory investigations. The key principle is 'thiamine before glucose' to prevent precipitating or worsening encephalopathy."

"Prognosis depends on early recognition and adequate treatment. Without treatment, mortality approaches 20% and up to 80% progress to irreversible Korsakoff's syndrome."

Common Mistakes (What Gets You Failed)

❌ Waiting for MRI or blood tests before giving thiamine

• WE is a clinical diagnosis; treatment is urgent and safe; delay risks irreversible brain damage

❌ Giving glucose before thiamine in a hypoglycemic alcoholic

• This can precipitate acute WE; always give thiamine first or simultaneously

❌ Prescribing oral thiamine for acute WE

• Oral absorption is inadequate in alcoholics; IV route is essential

❌ Forgetting magnesium replacement

• Thiamine won't work without magnesium; check and replace aggressively

❌ Missing the diagnosis due to reliance on the classic triad

• Only 10-16% have the full triad; use Caine criteria; high index of suspicion

❌ Failing to recognize non-alcoholic causes (especially hyperemesis gravidarum)

• Missed WE in pregnancy is a major litigation risk; high index of suspicion required

❌ Under-dosing thiamine (e.g., single pair of Pabrinex or oral only)

• Acute WE requires high-dose IV: 2-3 pairs of Pabrinex TDS for 3-5 days

❌ Telling a KS patient family to expect full recovery

• Only 20% recover significantly; most need long-term institutional care; realistic counseling essential

---

14. Patient and Layperson Explanation

What is "Wet Brain"?

"Wet brain" is a non-medical term for a serious brain condition caused by a lack of vitamin B1 (thiamine). When your body doesn't get enough thiamine for several weeks, certain parts of your brain start to malfunction and can be permanently damaged.

Why does it happen?

The most common cause is heavy alcohol use over many years. Alcohol stops your body from absorbing thiamine properly, and people who drink heavily often don't eat enough nutritious food. But it can also happen to anyone who isn't getting enough food or vitamins, such as:

• Pregnant women with severe vomiting (hyperemesis)
• People who have had weight-loss surgery (gastric bypass)
• People with severe eating disorders (anorexia)
• Cancer patients undergoing chemotherapy

What are the symptoms?

There are two stages:

Stage 1: Wernicke's Encephalopathy (Acute Phase) This is the sudden phase. Symptoms include:

• Confusion and disorientation (not knowing where you are or what day it is)
• Unsteady walking (like being drunk even when sober)
• Eye problems (double vision, eyes not moving properly, shaking eyes)

If treated quickly with vitamin B1 injections, this stage can often be reversed.

Stage 2: Korsakoff's Syndrome (Chronic Phase) If the first stage isn't treated quickly enough, it can turn into permanent brain damage. The main problem is severe memory loss:

• Cannot form new memories (you could have a conversation with someone, they leave the room for 5 minutes, and when they come back you don't remember they were just there)
• May lose some past memories, especially recent years
• May make up stories to fill in the memory gaps (called "confabulation")—not lying, but the brain trying to make sense of the missing information

This stage is largely permanent and irreversible.

How is it treated?

Emergency treatment:

• High-dose vitamin B1 injections into a vein (not just tablets, which don't work fast enough)
• Given multiple times a day for several days
• Critical rule: If someone is also low on blood sugar, vitamin B1 must be given before giving sugar, otherwise it can make the condition worse

Long-term:

• Continue taking vitamin B1 tablets
• Stop drinking alcohol
• Eat a balanced, nutritious diet
• Some people need to live in a care facility because they can't remember things well enough to live safely on their own

Can it be prevented?

Yes, if you're at risk:

• If you drink heavily, take vitamin B1 supplements
• If you're vomiting a lot (especially in pregnancy), tell your doctor—you may need vitamin injections
• If you've had weight-loss surgery, take your vitamins every day

What's the outlook?

• If treated immediately: Eye problems often get better within days. Confusion and walking problems may improve over weeks to months. Many people recover well.
• If treatment is delayed: There's a high chance of permanent memory problems (Korsakoff's syndrome). Most people with this need long-term care and cannot live independently.

The key message: Early recognition and immediate treatment with vitamin B1 can prevent permanent brain damage. If you or someone you know is at risk and develops confusion, eye problems, or unsteady walking, seek emergency medical help immediately.

---

15. References

1. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442-55. doi:10.1016/S1474-4422(07)70104-7

2. Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff's psychosis. Alcohol Alcohol. 2006;41(2):151-8. doi:10.1093/alcalc/agh249

3. Arts NJ, Walvoort SJ, Kessels RP. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875-2890. doi:10.2147/NDT.S130078

4. Oudman E, Wijnia JW, Oey MJ, et al. Preventing Wernicke's encephalopathy in anorexia nervosa: A systematic review. Psychiatry Clin Neurosci. 2018;72(10):774-779. doi:10.1111/pcn.12735

5. Scalzo SJ, Bowden SC, Ambrose ML, et al. Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86(12):1362-1368. doi:10.1136/jnnp-2014-309598

6. Isenberg-Grzeda E, Kutner HE, Nicolson SE. Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics. 2012;53(6):507-16. doi:10.1016/j.psym.2012.04.008

7. Thomson AD, Cook CC, Touquet R, Henry JA. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol. 2002;37(6):513-21. doi:10.1093/alcalc/37.6.513

8. National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis and management of physical complications. Clinical Guideline CG100. London: NICE; 2010 (updated 2017).

9. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49(4):341-5. doi:10.1136/jnnp.49.4.341

10. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44(2):136-40. doi:10.1093/alcalc/agn102

11. Chiossi G, Neri I, Cavazzuti M, et al. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006;61(4):255-68. doi:10.1097/01.ogx.0000206336.08794.65

12. Oudman E, Wijnia JW, Oey M, et al. Wernicke's encephalopathy in hyperemesis gravidarum: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2019;236:84-93. doi:10.1016/j.ejogrb.2019.03.006

13. Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51-60. doi:10.1136/jnnp.62.1.51

14. Galvin R, Brathen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408-18. doi:10.1111/j.1468-1331.2010.03153.x

15. Martin PR, Singleton CK, Hiller-Sturmhöfel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27(2):134-42.

16. Butterworth RF. Thiamine deficiency and brain disorders. Nutr Res Rev. 2003;16(2):277-84. doi:10.1079/NRR200367

17. Dyckner T, Ek B, Nyhlin H, Wester PO. Aggravation of thiamine deficiency by magnesium depletion: a case report. Acta Med Scand. 1985;218(1):129-31. doi:10.1111/j.0954-6820.1985.tb08835.x

18. Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review. Neurology. 2007;68(11):807-11. doi:10.1212/01.wnl.0000256812.29648.86

19. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17(7-8):632-7. doi:10.1016/s0899-9007(01)00542-1

20. Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg. 2008;248(5):714-20. doi:10.1097/SLA.0b013e3181884308

21. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid Based Complement Alternat Med. 2006;3(1):49-59. doi:10.1093/ecam/nek009

22. Gibson GE, Blass JP. Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxid Redox Signal. 2007;9(10):1605-19. doi:10.1089/ars.2007.1766

23. Bonnet U. Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function. Pharmacopsychiatry. 2013;46(1):35-6. doi:10.1055/s-0032-1314844

24. Zuccoli G, Santa Cruz D, Bertolini M, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol. 2009;30(1):171-6. doi:10.3174/ajnr.A1280

25. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol. 1998;171(4):1131-7. doi:10.2214/ajr.171.4.9762013

26. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition. 2nd ed. Philadelphia: FA Davis; 1989.

27. Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol. 2009;192(2):501-8. doi:10.2214/AJR.07.3959

28. Sica DA. Loop diuretic therapy, thiamine balance, and heart failure. Congest Heart Fail. 2007;13(4):244-7. doi:10.1111/j.1527-5299.2007.06452.x

29. Chamorro AJ, Rosón-Hernández B, Medina-García JA, et al. Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment. In Vivo. 2010;24(2):231-3. PMID:20363738

30. Wijnia JW, Oudman E, van Gool AR, et al. Long-term mortality of patients with an alcohol-related Wernicke-Korsakoff syndrome. Alcohol Alcohol. 2017;52(4):466-471. doi:10.1093/alcalc/agx027

31. Moskowitz A, Graver R, Gennis P, et al. Acute encephalopathy due to thiamine deficiency (Wernicke's encephalopathy) in a chronic hemodialyzed patient: a case report. Mt Sinai J Med. 1991;58(5):421-3. PMID:1855320

32. Cruickshank AM, Telfer AB, Shenkin A. Thiamine deficiency in the critically ill. Intensive Care Med. 1988;14(4):384-7. doi:10.1007/BF00262893

33. Abdou E, Hazell AS. Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations. Neurochem Res. 2015;40(2):353-61. doi:10.1007/s11064-014-1430-z

34. Spindler L, Bilic P, Gosar D, et al. Wernicke's encephalopathy in a patient with anorexia nervosa: case report and literature review. J Eat Disord. 2021;9(1):27. doi:10.1186/s40337-021-00383-w

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and follow local guidelines.